AAMRI 2022 Election Statement

AAMRI 2022 Election Statement

26th April, 2022

This election AAMRI is calling on all parties and candidates to prioritise, fund and ensure the long-term security of medical research, and its highly skilled workforce.

AAMRI has outlined three critical priorities:

  • Develop a national health and medical research strategy that sets out Australia’s research priorities and investments.
  • Develop a national health and medical research workforce plan, paired with immediate initiatives to attract and retain Australia’s next generation of research leaders.
  • Build Australia’s medical research investment through the NHMRC and MRFF to $3 billion per year by 2032.

You can read our Election Statement in full here.

Watch our short video outlining AAMRI’s election priorities below:

“To keep Australia’s healthcare system strong, resilient and sustainable, we need continued strong support for Australian health and medical research, especially our talented workforce.” – Professor Kathryn North, AC, AAMRI President.

Priority 1: Develop a national health and medical research strategy that sets out Australia’s research priorities and investments.

1.1 Develop a health and medical research strategy for Australia that

  • strategically aligns research priorities of medical research funders, ensuring a balance of investment across the pipeline from early discovery to patient care.
  • coordinates medical research funding through a whole of system approach.

The strategy should align with the national health and medical research workforce plan (Priority Action 2.1).

Priority 2: Develop a national health and medical research workforce plan, paired with immediate initiatives to attract and retain Australia’s next generation of research leaders.

2.1 Develop and implement a national health and medical research workforce plan as an urgent priority, focussing on early and mid-career researchers and improving gender equity and diversity, sustainable career pathways, training and actions to build a clinician-researcher workforce.

2.2 Continue to invest MRFF funding in initiatives that build a broad base of entrepreneurial skills in the research workforce and foster pathways for greater mobility between industry, healthcare and academic research settings.

Priority 3: Build Australia’s medical research investment through the NHMRC and MRFF to $3 billion per year by 2032.

3.1 Continue Australia’s strong support for new discoveries by increasing the NHMRC annual budget to $2 billion by 2032 (and then indexed annually).

3.2 Modify the MRFF’s investment mandate to seek greater returns with an annual MRFF disbursement target of $1 billion per year by 2032 (and then indexed annually).